Paper Details

  1. Home
  2. Paper Details

Pharmacological approaches to the management of schizophrenia: 10 years on.

Author: BurrowsGraham, CastleDavid, CopolovDavid, KeksNicholas, NewtonRichard, PaolettiNick, SchweitzerIsaac, TillerJohn

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Meta-AnalysisA statistical technique that integrates the results of multiple studies to draw more general conclusions about a particular issue.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.

Overview

Newer antipsychotics have been developed to treat schizophrenia, but they have not led to significant improvements in overall treatment efficacy. While some newer agents might be better than older ones for negative and cognitive symptoms, they still have metabolic side effects and hyperprolactinaemia.
Paper Details　
Original Abstract of the Article :
OBJECTIVE: To review the contemporary landscape regarding pharmacological treatments for schizophrenia. METHOD: Selective literature review. RESULTS: Newer antipsychotic agents include aripiprazole, asenapine, paliperidone, sertindole and ziprasidone. Each has some particular benefits and some sho...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1177/1039856213486211

データ提供：米国国立医学図書館（NLM）

Pharmacological Approaches to Schizophrenia Management

Schizophrenia is a complex mental health condition that can be challenging to manage. This study reviews the current landscape of pharmacological treatments for schizophrenia, highlighting the benefits and limitations of newer antipsychotic agents, including aripiprazole, asenapine, paliperidone, sertindole, and ziprasidone. The researchers discuss the effectiveness of these agents in treating various symptoms of schizophrenia, including positive, negative, and cognitive symptoms, as well as their potential metabolic side effects.

Finding a Path Through the Desert of Schizophrenia Treatment

This review navigates the diverse landscape of pharmacological treatments for schizophrenia, providing a comprehensive overview of available options. The researchers explore the effectiveness of newer antipsychotic agents in managing various symptoms and address the ongoing challenges of metabolic side effects. It's like exploring a vast desert of potential treatments, seeking the best approach to navigate the challenges of schizophrenia.

Hope for a Brighter Future for Schizophrenia Patients

This review highlights the ongoing progress in developing more effective and tolerable treatments for schizophrenia. While challenges remain, the study underscores the importance of continued research to improve patient outcomes. It's like finding new oases in the desert, offering hope for a brighter future for individuals with schizophrenia.

Dr.Camel's Conclusion

This review provides a valuable overview of the current pharmacological landscape for schizophrenia treatment. It highlights the benefits and limitations of newer antipsychotic agents, emphasizing the importance of finding the right treatment approach for individual patients. It's a reminder that the journey through the desert of schizophrenia treatment is often challenging, but with continued research and personalized care, we can find paths to improved outcomes and a better quality of life for those affected by this condition.

Date :
  1. Date Completed 2014-03-24
  2. Date Revised 2017-11-16
Further Info :

Pubmed ID

23616381

DOI: Digital Object Identifier

10.1177/1039856213486211

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.